Juan Ramón Gras-Cabrerizo

Prof. Dr. Juan Ramón Gras-Cabrerizo


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in American Journal of Rhinology & Allergy
Verified
Journal Article
Closed access
JGJuan Ramón Gras-Cabrerizo
Juan Ramón Gras-Cabrerizo
JMJoan R. Montserrat-Gili
Joan R. Montserrat-Gili
HMHumbert Massegur-Solench
Humbert Massegur-Solench
XLXavier Leon
Xavier Leon
JJJulia De Juan
Julia De Juan
JFJosep M. Fabra-Llopis
Josep M. Fabra-Llopis
Background: The aim of this study was to describe treatment results in patients with sinonasal inverted papilloma and to compare recent classification staging systems. Methods: We performed a retrospective study of 79 patients with primary paranasal sinus inverted papilloma from 1978 to 2008. Results: The median age at diagnosis was 59 years. There were 68 men (86%) and 11 women (14%). Sixty inverted papilloma (76%) were located in the ethmoidal sinus complex, 16 (20%) were in the maxillary sinus, 2 were in the sphenoid sinus (3%), and 1 was in the septum (1%). Malignancy was simultaneously associated in four cases (5%). Intracranial extension was found in five patients (6%) and we did not find orbital content involvement. The external approach was used in 22 cases (28%) and 57 patients were treated with endoscopic nasal resection (72%). The overall recurrence rate in the total population was 21%. Recurrences were observed in 7 cases (32%) in the group of patients who received external approach and in 10 (17%) patients in the endoscopic group. Recurrences according to the Krouse system were 0% in T1 stage, 16% in T2 stage, 25% in T3 stage, and 60% in T4 stage (p = 0.05). Recurrences for groups A, B, and C stages using the Cannady staging system were 12, 26, and 60%, respectively (p = 0.039). Recurrences according to Han's system were 19% in both T1 and T2, 20% in T3, and 60% in T4 (p > 0.05). Conclusions: Our results support the endoscopic approach as the treatment of choice when feasible in patients with inverted papilloma, combined in selected cases with external approaches. The Krouse and Cannady systems provided a good distribution of patients according to local control.

27 July 2010 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
JGJuan Ramón Gras-Cabrerizo
Juan Ramón Gras-Cabrerizo
HMHumbert Massegur-Solench
Humbert Massegur-Solench
APAlbert Pujol-Olmo
Albert Pujol-Olmo
JMJoan R. Montserrat-Gili
Joan R. Montserrat-Gili
JAJoan M. Ademá-Alcover
Joan M. Ademá-Alcover
IZIñaki Zarraonandia-Andraca
Iñaki Zarraonandia-Andraca

6 January 2016 in Surgical and Radiologic Anatomy
Verified
Journal Article
Closed access
PDF file
JGJuan Ramón Gras-Cabrerizo
Juan Ramón Gras-Cabrerizo
EGElena García-Garrigós
Elena García-Garrigós
JAJoan M. Ademá-Alcover
Joan M. Ademá-Alcover
ASAdolfo Sarandeses-Garcia
Adolfo Sarandeses-Garcia
MMMaria Martel-Martin
Maria Martel-Martin
HMHumbert Massegur-Solench
Humbert Massegur-Solench

26 November 2024 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
María Jesús Rojas-LechugaMaría Jesús Rojas-Lechuga
María Jesús Rojas-Lechuga
SJSara Jubés
Sara Jubés
MMManuel Molina-García
Manuel Molina-García
RSRui Milton Patricio da Silva-Junior
Rui Milton Patricio da Silva-Junior
CSClaudio Sampieri
Claudio Sampieri
IAIsam Alobid
Isam Alobid
Background/Objectives: Sinonasal mucosal melanomas (SNMMs) are rare and aggressive malignancies with poor survival outcomes. Our systematic review and meta-analysis aim to evaluate overall survival (OS) rates in patients with SNMM; Methods: We conducted a systematic search, following PRISMA guidelines across PubMed, Web of Science (WOS), and citation searching for studies reporting survival and prognosis outcomes for SNMMs. Inclusion criteria included studies with 5-year OS rates. Studies were excluded if they included tumor sites other than the paranasal sinuses or nasal cavity, were published in languages other than English and Spanish, or had a sample size of fewer than 15 patients. Two reviewers independently screened studies, extracted data, and assessed study quality using the Joanna Briggs Institute (JBI) critical appraisal checklist. Analyses of survival probabilities were conducted. Meta-analyses were performed using a random-effects model. PROSPERO ID CRD42024565137; Results: A total of 515 articles were identified after removing duplicates, and 99 reports were assessed for eligibility. Of these, 35 studies were included in the meta-analysis, encompassing a total of 2383 SNMM patients, of whom 1192 (50%) were female, with a weighted mean age of 65.4 years (SD = 5.4). Fifteen studies were from Europe (42.9%), six (17.1%) were from America, eleven (31.4%) were from Asia, two (5.7%) were from Australia, and one (2.9%) combined European, United Kingdom, and American populations. The 5-year OS was 34.8 [95% CI = 30.6–39.5], with the highest OS in America at 40.5 [95% CI = 34.1–48.1], followed by Europe at 36.6 [95% CI = 30.6–43.7], Australia at 32.3 [95% CI = 12.5–83.8], and Asia at 28.1 [95% CI = 19.5–40.7]. The age-standardized incidence rate (ASIR) for SNMM ranges was between 0.07 and 0.14 per 100,000 persons/year, with a slightly higher incidence in women than in men; Conclusions: This meta-analysis, one of the largest to date on SNMM, confirms the aggressive nature of this melanoma subtype with poor survival outcomes. Despite geographic differences in survival rates, the overall 5-year survival remains low, highlighting the urgent need for improved treatment strategies and more research to improve patient outcomes.

1 March 2015 in Acta Otorrinolaringológica Española
Verified
Journal Article
Closed access
MMMaría Martel-Martín
María Martel-Martín
JGJuan Ramón Gras-Cabrerizo
Juan Ramón Gras-Cabrerizo
CBCarolina Bothe-González
Carolina Bothe-González
JMJoan R. Montserrat-Gili
Joan R. Montserrat-Gili
MJManuel De Juan-Delago
Manuel De Juan-Delago
HMHumbert Massegur-Solench
Humbert Massegur-Solench

1 July 2016 in Acta Otorrinolaringológica Española
Verified
Journal Article
Closed access
JLJoan Lop
Joan Lop
JGJuan Ramón Gras-Cabrerizo
Juan Ramón Gras-Cabrerizo
CBCarolina Bothe-González
Carolina Bothe-González
JMJuan R. Montserrat-Gili
Juan R. Montserrat-Gili
ASAnna Sumarroca-Trouboul
Anna Sumarroca-Trouboul
HMHumbert Massegur-Solench
Humbert Massegur-Solench